Intensive Care Medicine

Intra-Abdominal Hypertension and Abdominal Compartment Syndrome

"Define IAH and ACS. Outline the grading system for IAH."... CICM Second Part exam preparation.

Updated 24 Jan 2026
43 min read

Clinical board

A visual summary of the highest-yield teaching signals on this page.

Linked comparisons

Differentials and adjacent topics worth opening next.

  • Acute Mesenteric Ischemia
  • Pancreatitis
0
Clinical reference article

Intra-Abdominal Hypertension and Abdominal Compartment Syndrome

Quick Answer

Intra-Abdominal Hypertension (IAH) is sustained elevation of intra-abdominal pressure (IAP) ≥12 mmHg. Abdominal Compartment Syndrome (ACS) occurs when IAP exceeds 20 mmHg and causes new organ dysfunction. Measurement is via intravesical pressure (bladder technique with 25 mL saline instillation at end-expiration). Management follows a stepwise approach: medical decompression (nasogastric drainage, sedation, paralytics, fluid removal) followed by surgical decompression (laparotomy) for refractory cases. Abdominal Perfusion Pressure (APP = MAP - IAP) should be maintained greater than 60 mmHg. Untreated ACS carries mortality approaching 100%, while decompressive laparotomy reduces this to 40-50%. [1,2]

CICM Exam Focus

High-Yield Topics

  • Definitions: IAH (≥12 mmHg) vs ACS (greater than 20 mmHg + organ dysfunction)
  • Grading system: Grades I-IV (12-15, 16-20, 21-25, greater than 25 mmHg)
  • Measurement technique: Intravesical gold standard, 25 mL instillation, end-expiration
  • Abdominal Perfusion Pressure: APP = MAP - IAP, target greater than 60 mmHg
  • Organ effects: Cardiovascular (↓CO), renal (AKI), respiratory (↓compliance), neurological (↑ICP)
  • Medical management: Five-point approach (evacuate contents/fluids, improve wall compliance, optimize perfusion)
  • Surgical decompression: Indications, techniques, temporary closure (NPWT)

Common SAQ Stems

  1. "Define IAH and ACS. Outline the grading system for IAH."
  2. "Describe the technique for measuring intra-abdominal pressure."
  3. "Explain the pathophysiology of acute kidney injury in abdominal compartment syndrome."
  4. "Outline the medical management of intra-abdominal hypertension."
  5. "List the indications for decompressive laparotomy in ACS."

Common Viva Themes

  • Risk factor identification (burns, pancreatitis, trauma, sepsis)
  • Measurement technique and troubleshooting
  • Stepwise escalation of treatment
  • Decision-making for surgical decompression
  • Post-operative management of open abdomen

Key Points

  1. IAH is defined as sustained IAP ≥12 mmHg; ACS requires IAP greater than 20 mmHg with new organ dysfunction [1,2]
  2. Grading: I (12-15), II (16-20), III (21-25), IV (greater than 25 mmHg) guides management intensity [2]
  3. Measurement: Intravesical technique is gold standard—25 mL saline, supine position, end-expiration, transducer at mid-axillary line [3,4]
  4. APP resuscitation (MAP - IAP greater than 60 mmHg) may improve outcomes compared to MAP-guided alone [5,6]
  5. Medical management first: Nasogastric decompression, sedation/analgesia, neuromuscular blockade, fluid removal, rectal decompression [2,7]
  6. Surgical decompression for refractory ACS: reduces mortality from ~100% to 40-50% [8,9]
  7. Risk factors: Massive fluid resuscitation (greater than 5L/24h), severe burns (TBSA greater than 30%), pancreatitis, trauma with damage control surgery, sepsis [10,11]
  8. Multi-organ effects: Renal (venous congestion, ↓perfusion pressure), cardiovascular (↓venous return, ↑afterload), respiratory (↓compliance, atelectasis), neurological (↑ICP via ↑CVP) [12,13,14]

Clinical Overview

Background

Intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS) represent a continuum of pathologically elevated intra-abdominal pressure causing progressive organ dysfunction and, if untreated, death. First described systematically in the 1980s, IAH/ACS is now recognized as a common complication in critically ill patients, occurring in 30-50% of ICU admissions with specific risk factors. [1,15]

The World Society of the Abdominal Compartment Syndrome (WSACS), now the Abdominal Compartment Society, has published consensus definitions and clinical practice guidelines that form the basis for diagnosis and management worldwide. [1,2]

Definitions (WSACS 2013 Consensus)

Intra-Abdominal Pressure (IAP)

  • The steady-state pressure within the abdominal cavity
  • Normal range: 5-7 mmHg in critically ill adults
  • Measured in mmHg and expressed at end-expiration in the supine position

Intra-Abdominal Hypertension (IAH)

  • Sustained or repeated pathological elevation of IAP ≥12 mmHg
  • Classified into four grades:
    • "Grade I: IAP 12-15 mmHg"
    • "Grade II: IAP 16-20 mmHg "
    • "Grade III: IAP 21-25 mmHg"
    • "Grade IV: IAP greater than 25 mmHg"

Abdominal Compartment Syndrome (ACS)

  • Sustained IAP greater than 20 mmHg (with or without APP below 60 mmHg)
  • Associated with new organ dysfunction/failure
  • Can be categorized as:
    • "Primary ACS: Associated with abdominal/pelvic pathology (trauma, hemoperitoneum, abscess)"
    • "Secondary ACS: No obvious abdominal cause (massive resuscitation, sepsis, burns)"
    • "Recurrent ACS: ACS that redevelops after previous surgical/medical treatment"
    • "Tertiary ACS: ACS developing after treatment of primary or secondary ACS"

Abdominal Perfusion Pressure (APP)

  • Calculated as: APP = MAP - IAP
  • Target: APP ≥60 mmHg
  • May be superior to conventional resuscitation endpoints (MAP alone) [5,6]

[1,2,16]

Epidemiology

Incidence

  • ICU patients: IAH occurs in 30-50% of mixed ICU populations [15,17]
  • Trauma patients: 40-60% develop IAH; 5-10% progress to ACS [18]
  • Severe acute pancreatitis: 60-80% develop IAH; 20-30% develop ACS [19]
  • Major burns (TBSA greater than 30%): 30-40% develop IAH; 10-15% develop ACS [20]
  • Damage control surgery: 20-35% develop ACS requiring open abdomen [21]

Mortality

  • Untreated ACS: Mortality approaches 90-100% [8]
  • Treated ACS (decompressive laparotomy): Mortality 40-50% overall [8,9]
    • "Primary ACS (trauma): 35-45% mortality [22]"
    • "Secondary ACS (medical/sepsis): 50-70% mortality [23]"
  • IAH without ACS: Associated with 2-3 fold increase in mortality risk [24]

Prognostic Factors

Poor prognostic indicators include:

  • Late decompression (after irreversible organ failure)
  • Number of failing organs at time of intervention
  • Pre-operative lactate greater than 5 mmol/L
  • Inability to achieve primary fascial closure
  • Ongoing intra-abdominal sepsis

[9,22,25]

Pathophysiology

Elevated IAP acts as a compartment syndrome affecting multiple organ systems through both direct compression and systemic inflammatory responses.

Cardiovascular Effects

Mechanism:

  • ↑IAP → compression of inferior vena cava (IVC) → ↓venous return → ↓preload
  • ↑IAP → compression of abdominal aorta → ↑systemic vascular resistance (SVR) → ↑afterload
  • ↑intrathoracic pressure (transmitted via diaphragm) → ↓venous return
  • Net effect: Decreased cardiac output despite elevated central venous pressure (CVP)

Clinical manifestation:

  • Hypotension despite adequate filling pressures
  • Elevated CVP that does not reflect true intravascular volume
  • Reduced response to fluid boluses
  • Increased vasopressor requirements

[12,26]

Renal Effects

Mechanism (Triple Hit):

  1. Reduced Renal Perfusion Pressure:

    • Effective RPP = MAP - IAP
    • As IAP rises, RPP falls even if systemic MAP is maintained

  2. Renal Venous Congestion:

    • Compression of renal veins and IVC
    • ↑renal venous pressure → ↓trans-glomerular pressure gradient
    • Immediate ↓GFR

  3. Direct Parenchymal Compression:

    • ↑intra-capsular pressure
    • Compression of ureters (functional obstruction)

  4. Neurohormonal Activation:

    • ↓effective circulating volume → RAAS activation
    • Sympathetic activation → renal vasoconstriction
    • Antidiuretic hormone release → water retention

Clinical progression:

  • Oliguria at IAP 12-15 mmHg
  • Marked oliguria/anuria at IAP greater than 30 mmHg
  • AKI develops in 60-80% of ACS patients
  • Renal function typically recovers after successful decompression

[27,28,29]

Respiratory Effects

Mechanism:

  • ↑IAP → cephalad displacement of diaphragm → ↓thoracic volume
  • Direct compression of lung bases → atelectasis
  • ↑pleural pressure (50% of IAP transmitted across diaphragm)
  • ↓chest wall compliance (primary defect)
  • ↓functional residual capacity (FRC)
  • V/Q mismatch from basal atelectasis

Clinical manifestation:

  • ↑peak inspiratory pressures (PIP)
  • ↑plateau pressures (Pplat)
  • ↓total respiratory system compliance
  • Hypoxemia (↑A-a gradient)
  • Hypercarbia (↓minute ventilation)
  • Risk of ventilator-induced lung injury (VILI) if high pressures used

Important consideration:

  • High plateau pressures may not reflect high transpulmonary pressure
  • Transpulmonary pressure = Airway pressure - Pleural pressure
  • Since pleural pressure is elevated in IAH, lung stress may be lower than Pplat suggests

[30,31,32]

Neurological Effects

Mechanism:

  • ↑IAP → ↑central venous pressure (CVP) → impaired cerebral venous drainage
  • ↑CVP transmitted to intracranial compartment → ↑intracranial pressure (ICP)
  • ↓cerebral perfusion pressure (CPP = MAP - ICP)
  • Particularly relevant in traumatic brain injury (TBI) patients

Clinical significance:

  • ICP can increase by 1-2 mmHg for every 5 mmHg rise in IAP
  • May contribute to secondary brain injury
  • Decompression can improve ICP in selected patients

[33,34]

Hepatosplanchnic Effects

Mechanism:

  • Direct compression of hepatic and mesenteric vessels
  • ↓splanchnic perfusion → intestinal and hepatic ischemia
  • ↓hepatic artery and portal vein flow
  • Mucosal ischemia → bacterial translocation
  • Endotoxin release → systemic inflammatory response syndrome (SIRS)

Clinical manifestation:

  • Hepatic dysfunction (↑transaminases, ↑bilirubin)
  • Intestinal edema and ischemia
  • Ileus
  • Potential for bacterial translocation and sepsis

[35,36]

Risk Factors

The WSACS guidelines identify risk factors across multiple domains: [2,10]

High-Risk Conditions

Massive Fluid Resuscitation

  • Crystalloid greater than 5 L in first 24 hours
  • Positive fluid balance greater than 3.5 L/24h
  • Major transfusion protocol (greater than 10 PRBC units)
  • "Ivy Index" in burns: greater than 250 mL/kg in 24 hours [20]

Intra-Abdominal Pathology

  • Hemoperitoneum (trauma, ruptured AAA)
  • Damage control surgery with abdominal packing
  • Pneumoperitoneum (laparoscopy with insufflation)
  • Ascites (cirrhosis, peritoneal dialysis)
  • Intra-abdominal abscess or tumor
  • Acute pancreatitis (retroperitoneal inflammation)
  • Ileus/bowel obstruction/gastroparesis

Abdominal Wall Compliance Issues

  • Major burns with abdominal eschar (TBSA greater than 30%)
  • Tight primary fascial closure
  • Prone positioning
  • Morbid obesity (BMI greater than 30)

Systemic/Critical Illness

  • Sepsis/severe sepsis/septic shock
  • Capillary leak syndrome
  • Multiple organ dysfunction syndrome (MODS)
  • Acidosis (pH below 7.2)
  • Hypothermia (below 35°C)
  • Coagulopathy

[10,11,19,20,37]

Measurement of Intra-Abdominal Pressure

Intravesical (Bladder) Technique: Gold Standard

The trans-bladder technique is the accepted clinical standard for indirect IAP measurement. [3,4]

Equipment:

  • Standard urinary catheter (Foley)
  • Sterile saline (25 mL in syringe)
  • Pressure transducer system (arterial line tubing works well)
  • Three-way stopcock
  • Clamp

Technique (Kron Technique, Modified):

  1. Patient positioning: Supine, completely flat (0° head-of-bed)
  2. Zero reference point: Mid-axillary line at level of iliac crest
  3. Ensure relaxation:
    • Adequate sedation/analgesia
    • No abdominal muscle contraction
    • End-expiration timing
  4. Instillation: Inject maximum 25 mL sterile saline into bladder via catheter
  5. Allow equilibration: Wait 30-60 seconds
  6. Measure: Read pressure at end-expiration
  7. Record: Document IAP in mmHg with time, patient position, and clinical context

Key Validation Studies:

  • Original Kron technique (1984): First described bladder pressure correlation with IAP [38]
  • Fusco validation (2001): Demonstrated r=0.95 correlation between bladder and direct intraperitoneal pressure [4]
  • Malbrain volume study (2006): Confirmed 25 mL as optimal priming volume (larger volumes overestimate IAP) [39]

Measurement Timing:

  • On ICU admission if risk factors present
  • Every 4-6 hours if IAH diagnosed (Grade I-II)
  • Every 1-2 hours if severe IAH or ACS (Grade III-IV)
  • After any intervention aimed at reducing IAP

[3,4,38,39]

Alternative Measurement Techniques

Intragastric Pressure (via Nasogastric Tube)

  • Uses specialized NG tube with pressure balloon (e.g., CiMON system)
  • Advantage: Allows continuous monitoring
  • Indication: Contraindication to bladder measurement (bladder trauma, neurogenic bladder)
  • Validation: Good correlation with bladder pressure [40,41]

Direct Intraperitoneal Catheter

  • Air-filled capsule or saline column placed in peritoneal cavity
  • Gold standard for research
  • Rarely used clinically except in patients with existing peritoneal dialysis catheters
  • Higher infection risk [42]

Inferior Vena Cava Pressure

  • Measured via central venous catheter positioned in IVC
  • Correlates moderately with IAP
  • Not recommended as primary method

Continuous Monitoring Systems

  • Automated trans-bladder systems (e.g., Accuryn)
  • Reduce infection risk, allow trend analysis
  • Increasingly used in high-risk patients
  • Validation studies demonstrate reliability [43,44]

Clinical Presentation

Symptoms and Signs

IAH/ACS is often clinically silent until significant organ dysfunction develops. Most patients are critically ill, intubated, and sedated. Diagnosis requires high index of suspicion and routine IAP monitoring in at-risk patients.

General Findings:

  • Tense, distended abdomen (but not always present)
  • Abdominal pain (in conscious patients)
  • Recent major abdominal surgery or trauma
  • Massive fluid resuscitation requirement

Organ System Manifestations:

Cardiovascular:

  • Hypotension refractory to fluids
  • Elevated CVP paradoxically with hypotension
  • Increased vasopressor requirements
  • Narrow pulse pressure

Respiratory:

  • Worsening hypoxemia (↓PaO₂/FiO₂ ratio)
  • Rising ventilatory pressures (PIP, Pplat)
  • Difficulty achieving adequate tidal volumes
  • Elevated end-tidal CO₂

Renal:

  • Oliguria (below 0.5 mL/kg/h) or anuria
  • Rising creatinine
  • Progressive AKI

Gastrointestinal:

  • Ileus (absent bowel sounds)
  • Intolerance to enteral feeding
  • Abdominal distension

Neurological (if TBI coexists):

  • Rising ICP
  • Decreasing CPP
  • Neurological deterioration

[12,13,45]

Diagnosis

Diagnostic Criteria (WSACS):

IAH:

  • Sustained IAP ≥12 mmHg
  • Measured on ≥2 standardized measurements 4-6 hours apart

ACS:

  • Sustained IAP greater than 20 mmHg
  • PLUS new organ dysfunction in ≥1 system:
    • "Cardiovascular: Hypotension, shock requiring vasopressors"
    • "Respiratory: PaO₂/FiO₂ below 200, or compliance below 30 mL/cmH₂O"
    • "Renal: Oliguria (below 0.5 mL/kg/h), or rising creatinine"
    • "Hepatic: Rising bilirubin/transaminases"
    • "Gastrointestinal: Ischemia, ileus"

[1,2]

Investigations

IAP Measurement

Primary investigation: Intravesical pressure measurement (technique described above)

Calculate Abdominal Perfusion Pressure:

  • APP = MAP - IAP
  • Target: APP ≥60 mmHg
  • May guide resuscitation better than MAP alone [5,6]

Laboratory Investigations

Baseline:

  • Full blood count (FBC)
  • Urea, creatinine, electrolytes (monitor renal function)
  • Liver function tests (hepatic dysfunction)
  • Lactate (tissue perfusion marker; levels greater than 5 mmol/L predict poor outcomes)
  • Arterial blood gas (ABG):
    • Metabolic acidosis (lactic acidosis from hypoperfusion)
    • Respiratory acidosis (hypoventilation)
    • Hypoxemia

Serial monitoring:

  • Renal function every 6-12 hours
  • Lactate every 4-6 hours
  • ABG as clinically indicated

Imaging

Computed Tomography (CT):

  • Not required for diagnosis but may identify cause
  • Findings in IAH/ACS:
    • Ascites, hemoperitoneum
    • Bowel wall thickening and edema
    • Bowel distension
    • Round/collapsed IVC (venous compression)
    • Cephalad displacement of diaphragm
    • Bilateral basal atelectasis
  • Risk: Moving unstable patient; may worsen condition

Ultrasound:

  • Bedside POCUS can identify:
    • Free fluid (ascites, blood)
    • Bowel distension
    • IVC compression
  • Cannot measure IAP directly but can guide intervention (e.g., paracentesis)

Chest X-ray:

  • Elevated hemidiaphragms
  • Basal atelectasis
  • Reduced lung volumes

[46,47]

Management

Management follows a stepwise escalation from conservative medical measures to definitive surgical decompression. The WSACS algorithm provides a structured framework. [2,7]

Medical Management

Medical interventions aim to reduce IAP and optimize organ perfusion before surgical decompression becomes necessary. Success rates vary: 25-40% of Grade II-III IAH responds to medical therapy. [7]

1. Evacuate Intraluminal Contents

Nasogastric/Orogastric Decompression:

  • Insert large-bore NG/OG tube (Salem sump or equivalent)
  • Continuous or intermittent suction
  • Reduces gastric and upper intestinal distension

Prokinetic Agents:

  • Metoclopramide 10 mg IV q6h (contraindicated if obstruction suspected)
  • Erythromycin 200-250 mg IV q6h (motilin agonist)
  • Promote gastric emptying and intestinal transit

Colonic Decompression:

  • Rectal tube insertion
  • Enemas (saline, glycerin)
  • Neostigmine 2-2.5 mg IV over 5 minutes (if acute colonic pseudo-obstruction; requires cardiac monitoring due to bradycardia risk)
  • Colonoscopic decompression (rarely used in ICU)

[2,7,48]

2. Evacuate Intra-Abdominal Fluid Collections

Percutaneous Drainage:

  • Ultrasound or CT-guided drainage of:
    • Ascites (large-volume paracentesis)
    • Intra-abdominal abscesses
    • Hematomas (if accessible)
  • Can reduce IAP by 3-10 mmHg [49]

Diuresis:

  • Loop diuretics (furosemide) if volume overloaded
  • Goal: Negative fluid balance

Renal Replacement Therapy (RRT):

  • Continuous venovenous hemofiltration (CVVH) or hemodialysis
  • Aggressive ultrafiltration to remove excess fluid
  • May improve IAP by addressing fluid overload
  • Particularly useful in secondary ACS from massive resuscitation [50]

3. Improve Abdominal Wall Compliance

Sedation and Analgesia:

  • Goal: Eliminate voluntary and involuntary abdominal muscle contraction
  • Adequate depth of sedation (RASS -3 to -4)
  • Common agents:
    • Propofol infusion
    • Fentanyl or remifentanil infusion
    • Benzodiazepines (midazolam)

Neuromuscular Blockade (NMB):

  • Indication: Inadequate response to sedation alone
  • Agents:
    • Cisatracurium 0.15-0.2 mg/kg bolus, then infusion
    • Rocuronium infusion
  • Effect: Can reduce IAP by 2-8 mmHg [51]
  • Duration: Short trial (4-8 hours); reassess IAP
  • Monitoring: Train-of-four monitoring
  • Caution: Prolonged use associated with ICU-acquired weakness

Body Positioning:

  • Avoid head-down/Trendelenburg position (increases IAP)
  • Reverse Trendelenburg may slightly reduce IAP but risks hypotension
  • Supine, flat positioning generally optimal

Escharotomy (Burns):

  • If full-thickness abdominal burn eschar restricting wall expansion
  • Immediate surgical consultation
  • Can dramatically reduce IAP [20]

[2,7,51]

4. Optimize Fluid Administration

Avoid Ongoing Fluid Overload:

  • Goal-directed fluid therapy
  • Use dynamic indices (pulse pressure variation, stroke volume variation) if available
  • Restrict crystalloids once resuscitation targets met

De-resuscitation:

  • Active removal of excess fluid (as above: diuretics, RRT)
  • Target neutral to negative fluid balance

Hypertonic Saline/Colloids:

  • May reduce third-spacing (limited evidence)
  • Not routinely recommended

5. Optimize Systemic and Regional Perfusion

Abdominal Perfusion Pressure-Targeted Resuscitation:

  • Calculate APP = MAP - IAP
  • Target APP ≥60 mmHg (associated with improved survival compared to MAP-targeted alone) [5,6]
  • Use vasopressors (norepinephrine) to increase MAP if APP inadequate

Avoid Excessive Vasopressor Use:

  • High-dose vasopressors may worsen splanchnic ischemia
  • Balance between maintaining APP and avoiding mesenteric vasoconstriction

[5,6,52]

Surgical Management

Indications for Decompressive Laparotomy

Absolute Indications:

  • ACS refractory to maximal medical therapy
    • Sustained IAP greater than 20 mmHg with progressive organ dysfunction
    • Failure to respond to medical interventions within 4-6 hours
  • Life-threatening organ failure attributable to IAH:
    • Refractory hypotension/shock
    • Severe hypoxemia (PaO₂/FiO₂ below 100)
    • Anuria despite adequate resuscitation

Relative Indications:

  • Grade III-IV IAH (IAP 21-25 or greater than 25 mmHg) with worsening trend
  • APP below 60 mmHg despite maximal support
  • Clinical judgment: patient deteriorating despite aggressive medical therapy

Timing:

  • Early decompression (within 4-6 hours of ACS diagnosis) associated with better outcomes [9,25]
  • Delayed decompression (greater than 12-24 hours) correlates with increased mortality due to irreversible organ injury

[2,8,9,25]

Surgical Technique

Decompressive Laparotomy:

  1. Midline Laparotomy: Full-length incision for maximal decompression
  2. Evacuation: Remove blood, ascites, bowel contents (if perforation)
  3. Assess: Identify and address underlying pathology (bleeding, ischemia, perforation)
  4. Damage Control Principles:
    • Control hemorrhage (packing, ligation)
    • Control contamination (bowel resection, exteriorization)
    • Abbreviated procedure (avoid complex reconstruction)
  5. Leave Abdomen Open: Do NOT attempt primary fascial closure

Temporary Abdominal Closure (TAC):

Goal: Prevent evisceration, protect bowel, allow access, facilitate future closure.

Negative Pressure Wound Therapy (NPWT) - Preferred Method:

  • Commercial systems: ABThera (KCI), RENASYS (Smith & Nephew)
  • "Home-made" systems: Barker's vacuum pack technique
  • Technique:
    1. Non-adherent perforated plastic sheet over viscera
    2. Foam sponge (polyurethane or polyvinyl alcohol) over sheet
    3. Occlusive adhesive drape
    4. Negative pressure applied (-75 to -125 mmHg)
  • Advantages:
    • Removes inflammatory fluid (1-3 L/day)
    • Prevents lateral fascial retraction
    • Higher primary fascial closure rates (60-80%) [53,54]
    • Lower enteroatmospheric fistula rate

Alternative TAC Methods (if NPWT unavailable):

  • Bogota bag: Sterile IV fluid bag sewn to skin edges
  • Mesh (absorbable or non-absorbable): Vicryl mesh, polypropylene
  • "Sandwich" technique: Mesh + gauze + plastic coverage
  • Disadvantages: Lower closure rates, higher fistula risk, more lateral retraction

Dynamic Fascial Traction:

  • Progressive re-approximation of fascia using sutures, vessel loops, or commercial devices
  • Gradual closure over days to weeks
  • Goal: Achieve primary fascial closure (PFC) within 7-14 days

[53,54,55,56]

Post-Operative Management

ICU Monitoring:

  • Continue IAP monitoring every 4-6 hours
  • Monitor for recurrent IAH (occurs in 10-20%)
  • Watch for tertiary ACS: Redevelopment of ACS after initial treatment

Planned Re-laparotomy:

  • Typically 24-48 hours after initial decompression
  • Assess for:
    • Further resection needs
    • Bleeding control
    • Readiness for fascial closure
  • Serial re-looks every 48-72 hours until definitive closure or decision for planned ventral hernia

Fascial Closure Timing:

  • Early closure (within 7 days): Preferred; associated with lower morbidity
  • Monitor IAP during closure attempt (stop if IAP rises greater than 15 mmHg)
  • If cannot close: Continue TAC, attempt again in 3-5 days

Complications:

  • Enteroatmospheric fistula (EAF): 5-25% (higher with prolonged OA)
  • Wound infection: 20-40%
  • Planned ventral hernia: 20-50% if PFC not achieved
  • Intra-abdominal sepsis/abscess
  • Recurrent IAH/ACS: 10-20%

Long-term Issues:

  • Requirement for complex abdominal wall reconstruction
  • Incisional hernia repair with mesh
  • Functional impairment
  • Reduced quality of life

[54,55,57]

Prognosis

Overall Outcomes

Mortality:

  • Untreated ACS: 90-100% [8]
  • Treated ACS (decompressive laparotomy): 40-50% [8,9]
  • IAH without progression to ACS: Still associated with increased mortality (OR 2.1-3.4 vs no IAH) [24]

Predictors of Mortality:

  • Timing of decompression (late greater than 24h worse than early below 6h) [25]
  • Lactate greater than 5 mmol/L pre-operatively [9]
  • Number of organ failures at presentation [22]
  • Underlying etiology (secondary ACS worse than primary) [23]
  • Inability to achieve fascial closure (52% mortality vs 24% if closed) [58]

Organ Recovery

Renal:

  • AKI reversible in 60-80% if decompression performed early
  • 15-25% require temporary or permanent dialysis
  • Recovery often delayed (weeks to months)

Respiratory:

  • Immediate improvement in oxygenation and compliance post-decompression
  • Duration of mechanical ventilation prolonged (mean 14-21 days)

Cardiovascular:

  • Hemodynamics often improve within hours of decompression
  • Vasopressor requirements typically decrease

[27,59]

Long-term Morbidity

Survivors of ACS face significant long-term challenges:

  • Ventral hernia: 50-70% if abdomen left open greater than 10 days
  • Chronic pain: 40-60%
  • Bowel dysfunction: 30-50% (adhesions, short bowel if extensive resection)
  • Physical disability: Reduced functional status
  • Psychological sequelae: PTSD, depression (common in ICU survivors)

Quality of Life:

  • Significantly reduced in first 1-2 years
  • Gradual improvement with time and reconstructive surgery
  • Many patients unable to return to previous occupation

[57,60]

Special Populations

Severe Burns

  • High Risk: TBSA greater than 30%, fluid resuscitation greater than 250 mL/kg in 24h ("Ivy Index") [20]
  • Mechanism: Massive capillary leak + abdominal eschar reducing wall compliance
  • Unique Intervention: Escharotomy can reduce IAP without laparotomy
  • Mortality: ACS in burns carries 60-80% mortality

Acute Pancreatitis

  • Incidence: IAH in 60-80% of severe acute pancreatitis (SAP); ACS in 20-30% [19]
  • Mechanism: Retroperitoneal inflammation, ascites, ileus
  • Management: Medical therapy first (paracentesis if large-volume ascites); surgical decompression reserved for refractory cases or if necrotizing pancreatitis requires debridement
  • Prognosis: ACS in pancreatitis associated with 50-60% mortality

Trauma and Damage Control Surgery

  • High Risk: Damage control laparotomy with packing, massive transfusion protocol
  • Strategy: Planned open abdomen after initial operation to prevent ACS
  • Closure: Attempt within 3-7 days once resuscitation complete and physiologic derangements corrected
  • Outcomes: Early planned OA reduces ACS incidence from 30% to below 10% [21]

Pregnancy

  • Physiologic IAP Higher: Normal IAP in third trimester 10-15 mmHg (vs 5-7 mmHg non-pregnant)
  • Adjusted Thresholds: Some experts suggest IAH definition should be IAP ≥15 mmHg in pregnancy
  • Obstetric Causes: Uterine rupture, placental abruption, peripartum hemorrhage
  • Management: Similar principles; obstetric consultation essential
  • Delivery: Cesarean section may decompress abdomen if fetus viable

CICM Exam Practice

SAQ Practice Question 1

Question:

A 45-year-old man is in the ICU 24 hours after damage control surgery for a ruptured abdominal aortic aneurysm (AAA). He has received 12 L of crystalloid and 8 units of packed red blood cells. He is now oliguric (urine output 15 mL/h), hypotensive (MAP 62 mmHg on norepinephrine 0.3 mcg/kg/min), and has worsening hypoxemia (PaO₂/FiO₂ 150). His abdomen is tense and distended.

a) List four clinical features that suggest the diagnosis of abdominal compartment syndrome. (2 marks)

b) Describe the technique for measuring intra-abdominal pressure via the bladder. (4 marks)

c) His measured IAP is 28 mmHg and MAP is 62 mmHg. Calculate his abdominal perfusion pressure (APP) and state the target APP. (2 marks)

d) Outline the medical management options for this patient. (6 marks)

e) List three indications for decompressive laparotomy. (3 marks)

Model Answer:

a) Clinical features of ACS (2 marks):

  • Tense, distended abdomen
  • Oliguria/anuria (renal dysfunction)
  • Hypoxemia and increased ventilatory pressures (respiratory dysfunction)
  • Hypotension refractory to fluids (cardiovascular dysfunction)
  • Elevated CVP paradoxically with hypotension
  • Recent massive fluid resuscitation

(Award 0.5 marks each for 4 features)

b) Technique for measuring IAP via bladder (4 marks):

Patient preparation (1 mark):

  • Supine position, completely flat (0° head elevation)
  • Ensure adequate sedation/analgesia (no abdominal muscle contraction)
  • Measure at end-expiration

Equipment and setup (1 mark):

  • Standard urinary catheter (Foley) in situ
  • Pressure transducer system connected via three-way stopcock
  • Zero reference at mid-axillary line, level of iliac crest

Measurement (1.5 marks):

  • Instill maximum 25 mL sterile saline into bladder
  • Allow 30-60 seconds for equilibration
  • Measure pressure at end-expiration
  • Record IAP in mmHg

Interpretation (0.5 marks):

  • Normal IAP: 5-7 mmHg
  • IAH: ≥12 mmHg
  • ACS: greater than 20 mmHg with new organ dysfunction

c) APP calculation (2 marks):

APP = MAP - IAP

Given: MAP 62 mmHg, IAP 28 mmHg

APP = 62 - 28 = 34 mmHg (1 mark)

Target APP: ≥60 mmHg (1 mark)

d) Medical management (6 marks):

1. Evacuate intraluminal contents (1.5 marks):

  • Nasogastric tube insertion and decompression
  • Prokinetic agents (metoclopramide, erythromycin)
  • Rectal tube/enemas for colonic decompression

2. Evacuate intra-abdominal fluid (1 mark):

  • Percutaneous drainage of ascites/collections if present
  • Diuretics (furosemide) for fluid removal
  • Renal replacement therapy with ultrafiltration

3. Improve abdominal wall compliance (1.5 marks):

  • Optimize sedation and analgesia (eliminate muscle tone)
  • Neuromuscular blockade (e.g., cisatracurium)
  • Avoid head-down positioning

4. Optimize fluid management (1 mark):

  • Avoid further fluid overload
  • Goal-directed fluid therapy
  • Target negative fluid balance ("de-resuscitation")

5. Optimize perfusion (1 mark):

  • APP-targeted resuscitation (target APP ≥60 mmHg)
  • Increase MAP with vasopressors (norepinephrine) to achieve APP goal
  • Balance between perfusion and avoiding excessive vasopressor doses

e) Indications for decompressive laparotomy (3 marks):

(Award 1 mark each, any 3 of:)

  • ACS refractory to maximal medical therapy (sustained IAP greater than 20 mmHg with ongoing organ dysfunction despite 4-6 hours of medical management)
  • Life-threatening organ failure attributable to IAH (refractory shock, severe hypoxemia, anuria)
  • Grade IV IAH (IAP greater than 25 mmHg) with worsening trend
  • APP below 60 mmHg despite maximal vasopressor support
  • Clinical deterioration despite aggressive medical therapy

SAQ Practice Question 2

Question:

A 32-year-old woman with 40% total body surface area (TBSA) burns is admitted to the ICU. She has received 18 L of crystalloid in the first 24 hours. Her intra-abdominal pressure is measured at 24 mmHg. She is hypotensive (MAP 58 mmHg on norepinephrine 0.4 mcg/kg/min), oliguric (10 mL/h), and has an elevated plateau pressure of 38 cmH₂O.

a) Define intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS). (2 marks)

b) List the four grades of IAH with their corresponding IAP ranges. (2 marks)

c) Explain the pathophysiology of acute kidney injury in ACS (include three mechanisms). (3 marks)

d) Describe the cardiovascular effects of elevated intra-abdominal pressure. (3 marks)

e) Why might this patient be at particularly high risk of ACS? List three burn-specific risk factors. (3 marks)

f) What is a unique intervention for IAH/ACS in burn patients with abdominal eschar? (1 mark)

Model Answer:

a) Definitions (2 marks):

Intra-Abdominal Hypertension (IAH) (1 mark):

  • Sustained or repeated pathological elevation of intra-abdominal pressure ≥12 mmHg

Abdominal Compartment Syndrome (ACS) (1 mark):

  • Sustained IAP greater than 20 mmHg (with or without APP below 60 mmHg) associated with new organ dysfunction/failure

b) IAH Grading (2 marks):

  • Grade I: IAP 12-15 mmHg (0.5 marks)
  • Grade II: IAP 16-20 mmHg (0.5 marks)
  • Grade III: IAP 21-25 mmHg (0.5 marks)
  • Grade IV: IAP greater than 25 mmHg (0.5 marks)

c) Pathophysiology of AKI in ACS (3 marks):

Mechanism 1: Reduced renal perfusion pressure (1 mark):

  • Effective renal perfusion pressure = MAP - IAP
  • As IAP rises, perfusion pressure to kidneys falls even if systemic MAP maintained
  • Results in reduced renal blood flow and GFR

Mechanism 2: Renal venous congestion (1 mark):

  • Compression of renal veins and inferior vena cava
  • Increased renal venous pressure reduces trans-glomerular pressure gradient
  • Immediate decrease in glomerular filtration rate

Mechanism 3: Direct parenchymal compression (0.5 marks):

  • Physical compression increases intra-capsular pressure
  • Compression of ureters causing functional obstruction
  • Further opposes glomerular filtration

Additional mechanism: Neurohormonal activation (0.5 marks):

  • RAAS activation causing renal vasoconstriction
  • Sympathetic activation reducing renal blood flow
  • ADH release causing water retention

d) Cardiovascular effects (3 marks):

Effect 1: Reduced preload (1 mark):

  • Compression of inferior vena cava reduces venous return
  • Decreased cardiac preload despite elevated CVP
  • CVP elevation does not reflect true intravascular volume

Effect 2: Increased afterload (1 mark):

  • Compression of abdominal aorta increases systemic vascular resistance
  • Increased left ventricular afterload
  • Requires higher pressures to maintain cardiac output

Effect 3: Decreased cardiac output (1 mark):

  • Combined effect of reduced preload and increased afterload
  • Net result is decreased cardiac output
  • Hypotension despite adequate filling pressures
  • Increased vasopressor requirements

e) Burn-specific risk factors (3 marks):

(Award 1 mark each, any 3 of:)

  • Large TBSA (greater than 30% in this case; greater than 40% very high risk)
  • Massive fluid resuscitation (18 L meets "Ivy Index" threshold of greater than 250 mL/kg/24h for increased ACS risk)
  • Abdominal eschar (full-thickness burns on abdomen create non-compliant "abdominal wall compartment")
  • Capillary leak syndrome (systemic inflammation causes third-spacing into interstitial and peritoneal spaces)
  • Circumferential torso burns (restrict thoracoabdominal wall expansion)

f) Unique burn intervention (1 mark):

Escharotomy of abdominal wall

  • Surgical incisions through full-thickness burn eschar
  • Releases restrictive effect on abdominal wall
  • Can dramatically reduce IAP without need for laparotomy
  • May avoid or delay need for decompressive laparotomy

Viva Scenario 1: IAH/ACS Recognition and Initial Management

Stem:

You are the intensive care registrar. A 58-year-old man is Day 1 post-emergency laparotomy for perforated sigmoid diverticulitis. He underwent Hartmann's procedure. Intraoperatively he received 6 L crystalloid and 4 units packed red blood cells. His abdomen was closed primarily.

He is now deteriorating: MAP 55 mmHg on norepinephrine 0.25 mcg/kg/min, heart rate 118/min, SpO₂ 90% on FiO₂ 0.8, PEEP 12 cmH₂O. Urine output has been 10 mL in the last 2 hours. His abdomen appears tense.

Examiner Questions and Expected Responses:

Q1: What is your differential diagnosis for this patient's deterioration?

Expected answer:

  • Primary concern: Abdominal compartment syndrome (ACS)
    • "Risk factors: recent laparotomy, massive fluid resuscitation, intra-abdominal sepsis"
    • "Clinical features: tense abdomen, oliguria, hypoxemia, hypotension"
  • Alternative diagnoses to consider:
    • Ongoing intra-abdominal sepsis/anastomotic leak
    • Hemorrhage (though closed abdomen makes less likely)
    • Cardiogenic shock
    • Septic shock from source other than abdomen
    • Pulmonary embolism

Q2: How will you confirm your suspected diagnosis?

Expected answer:

  • Measure intra-abdominal pressure via intravesical (bladder) technique:
    • Use existing Foley catheter
    • Instill 25 mL sterile saline
    • Measure pressure at end-expiration with patient supine
    • Zero transducer at mid-axillary line, iliac crest level
  • Define IAH: IAP ≥12 mmHg
  • Define ACS: IAP greater than 20 mmHg PLUS new organ dysfunction
  • Calculate APP: MAP - IAP (target ≥60 mmHg)
  • Assess organ dysfunction:
    • "Renal: Oliguria present"
    • "Respiratory: Hypoxemia, likely elevated airway pressures"
    • "Cardiovascular: Hypotension, increased vasopressor needs"

Q3: His IAP measures 26 mmHg. What is his abdominal perfusion pressure and what are the implications?

Expected answer:

  • APP = MAP - IAP = 55 - 26 = 29 mmHg
  • Target APP is ≥60 mmHg
  • Current APP of 29 mmHg is critically low
  • Implications:
    • Inadequate abdominal organ perfusion
    • High risk of renal, hepatic, intestinal ischemia
    • Predictor of poor outcome if not corrected
    • Requires urgent intervention to increase APP (increase MAP and/or decrease IAP)

Q4: Outline your immediate management.

Expected answer:

Resuscitation/stabilization:

  • Increase MAP to improve APP:
    • Increase norepinephrine dose
    • Ensure adequate (but not excessive) intravascular volume
    • Target MAP to achieve APP ≥60 mmHg (requires MAP ~85 mmHg if IAP remains 26)
  • Optimize oxygenation/ventilation:
    • Increase FiO₂ to maintain SpO₂ ≥92%
    • May need to accept higher plateau pressures (pleural pressure elevated, so transpulmonary pressure may be acceptable)
    • Consider recruitment maneuvers cautiously

Medical management to reduce IAP:

  1. Evacuate intraluminal contents:
    • Ensure NG tube functioning, on suction
    • Rectal tube for colonic decompression
    • Prokinetics (metoclopramide, erythromycin)
  2. Improve abdominal wall compliance:
    • Optimize sedation (propofol, fentanyl)
    • Consider neuromuscular blockade trial (cisatracurium)
  3. Optimize fluid balance:
    • Stop ongoing fluid administration unless hypovolemic
    • Consider diuretics (furosemide)
  4. Drainage if applicable:
    • CT scan to assess for drainable collections (if stable enough to transfer)
    • Ultrasound-guided paracentesis if ascites

Escalation planning:

  • Notify surgical team immediately
  • Discuss need for decompressive laparotomy if medical management fails within 4-6 hours
  • Prepare for potential return to operating theatre

Q5: Despite 4 hours of maximal medical therapy (sedation, paralytics, NG decompression, diuresis), his IAP remains 24 mmHg. He now requires norepinephrine 0.6 mcg/kg/min to maintain MAP 65 mmHg. Urine output is 5 mL/h. What is your next step?

Expected answer:

  • Indication for decompressive laparotomy is met:
    • Refractory ACS (IAP greater than 20 mmHg, failed medical therapy)
    • Progressive multi-organ dysfunction (renal, cardiovascular)
    • APP remains inadequate despite maximum support
  • Urgent surgical consultation for return to theatre
  • Timing critical: Delay beyond this point associated with increased mortality
  • Procedure: Midline laparotomy, address any pathology, leave abdomen open with temporary closure (NPWT preferred)
  • Consent discussion (if patient competent or with family): High-risk procedure but necessary; explain open abdomen, likely need for multiple operations, risk of complications including death

Examiner may ask: What are the potential complications of leaving the abdomen open?

Expected answer:

  • Enteroatmospheric fistula (5-25%)
  • Infection/sepsis
  • Massive protein and fluid losses
  • Electrolyte derangements
  • Difficulty achieving fascial closure (may result in planned ventral hernia)
  • Prolonged ICU/hospital stay
  • Need for complex abdominal wall reconstruction

Viva Scenario 2: Severe Acute Pancreatitis with IAH

Stem:

A 42-year-old woman with severe acute necrotizing pancreatitis is admitted to ICU. CT severity index is 8/10. She has developed large-volume ascites and her abdomen is markedly distended. You measure her IAP and it is 18 mmHg. She is on 4 L/min nasal prongs, maintaining SpO₂ 94%. Urine output is 35 mL/h. Creatinine is rising (180 µmol/L, baseline 70).

Examiner Questions and Expected Responses:

Q1: Does this patient have IAH or ACS? Justify your answer.

Expected answer:

  • Diagnosis: Intra-Abdominal Hypertension (IAH), Grade II
    • "IAP 18 mmHg (definition: ≥12 mmHg)"
    • "Grade II: IAP 16-20 mmHg"
  • Does NOT yet meet criteria for ACS:
    • ACS requires IAP greater than 20 mmHg PLUS new organ dysfunction
    • Her IAP is 18 mmHg (below threshold)
    • While she has some organ dysfunction (rising creatinine, hypoxemia), the IAP threshold for ACS diagnosis is not met
  • However, at high risk of progression to ACS:
    • Severe acute pancreatitis is a major risk factor
    • Ascending trend of IAP likely
    • Already showing early renal dysfunction
  • Close monitoring required: Repeat IAP measurements every 4-6 hours

Q2: What are the specific mechanisms contributing to IAH in acute pancreatitis?

Expected answer:

  • Retroperitoneal inflammation and edema:
    • Peripancreatic fat necrosis and fluid collections
    • Inflammatory exudate
  • Ascites:
    • Pancreatic enzyme-rich exudative fluid
    • Increased capillary permeability
  • Ileus:
    • Inflammatory mediators affect bowel motility
    • Gastric and intestinal distension
  • Third-spacing from aggressive fluid resuscitation:
    • Capillary leak in severe pancreatitis
    • Large-volume crystalloid resuscitation standard of care but contributes to IAH

Q3: How would you manage this patient's IAH?

Expected answer:

Monitoring (1 point):

  • Serial IAP measurements every 4-6 hours
  • Monitor trend closely
  • Calculate APP (MAP - IAP), target ≥60 mmHg
  • Monitor organ function: urine output, creatinine, oxygenation, lactate

Medical management (multi-pronged approach):

  1. Evacuate intra-abdominal fluid:

    • Percutaneous paracentesis (large-volume drainage of ascites)
      • Can reduce IAP by 5-10 mmHg
      • Send fluid for analysis (amylase, culture)
    • Drain peripancreatic collections if safe and accessible (usually requires interventional radiology/endoscopic approach)

  2. Evacuate intraluminal contents:

    • NG tube decompression
    • Prokinetics (metoclopramide) if no ileus contraindication
    • Rectal decompression

  3. Optimize fluid management:

    • Judicious fluid resuscitation (goal-directed)
    • Avoid over-resuscitation
    • Consider diuretics once resuscitation adequate (de-resuscitation strategy)

  4. Improve abdominal wall compliance:

    • Adequate analgesia (important in pancreatitis for pain control anyway)
    • Sedation if required (though try to avoid if respiratory status allows spontaneous breathing)

  5. Treat underlying pancreatitis:

    • Identify and treat etiology (gallstones → ERCP if indicated)
    • Antibiotics if infected necrosis
    • Nutritional support (enteral preferred)

Escalation plan:

  • If IAP progresses to greater than 20 mmHg with worsening organ dysfunction → meets criteria for ACS
  • Surgical consultation
  • Decompressive laparotomy typically last resort in pancreatitis due to:
    • High infection risk
    • Contamination with pancreatic enzymes
    • Difficult abdomen to manage
    • Extremely high mortality (60-80%)
  • Prefer aggressive medical/percutaneous management

Q4: Over the next 12 hours, despite paracentesis removing 2.5 L of ascitic fluid and maximal medical therapy, her IAP rises to 22 mmHg. She now requires BiPAP for hypoxemia (PaO₂/FiO₂ 180) and is oliguric (20 mL/h). What are your options?

Expected answer:

  • Now meets criteria for ACS (IAP 22 mmHg + respiratory and renal dysfunction)
  • Options:

  1. Continue aggressive medical/percutaneous management:

    • Further paracentesis (ascites may reaccumulate)
    • Initiate renal replacement therapy (CVVH with ultrafiltration for fluid removal)
    • Neuromuscular blockade and mechanical ventilation (may need to intubate given worsening respiratory status)
    • High-risk strategy but avoids surgical abdomen in already critically ill patient

  2. Decompressive laparotomy:

    • Indications: Refractory ACS despite maximal medical therapy
    • Risks in pancreatitis:
      • Mortality 60-80% (very high)
      • Infection/sepsis
      • Pancreatic fistula
      • Bleeding from retroperitoneal necrotic tissue
    • Technique considerations:
      • May perform minimal debridement of necrotic tissue if accessible
      • Leave abdomen open with NPWT
      • Avoid aggressive debridement (staged approach better tolerated)
    • Timing: Last resort; ensure all medical options exhausted

Multidisciplinary discussion:

  • Involve senior ICU consultant, HPB/general surgeon, interventional radiology
  • Individualize decision based on overall trajectory, comorbidities, wishes
  • Consider goals of care discussion if prognosis very poor

Q5: What monitoring would you institute if you proceed with decompressive laparotomy?

Expected answer:

Post-operative ICU monitoring:

  • Continued IAP monitoring every 4-6 hours (risk of recurrent/tertiary ACS even with open abdomen)
  • APP calculation and targeting ≥60 mmHg
  • Organ function:
    • "Renal: Hourly urine output, daily creatinine, consider RRT if AKI persists"
    • "Respiratory: Continuous SpO₂, regular ABGs, ventilator parameters (expect improved compliance post-decompression)"
    • "Cardiovascular: Arterial line for continuous MAP, cardiac output monitoring (if available), vasopressor requirements"
    • "Hepatic: Daily LFTs (monitor for hepatic dysfunction)"
    • "Hematologic: Coagulation profile (DIC risk in severe pancreatitis)"
  • Fluid balance: Strict input/output; expect large losses from open abdomen (1-3 L/day)
  • Nutritional: Protein losses significant; aggressive nutritional support
  • Infection surveillance: Daily WBC, CRP/procalcitonin, wound inspection, blood/fluid cultures as indicated
  • Plan for re-laparotomy: Typically 24-48 hours for reassessment

Controversies and Evolving Concepts

Optimal Target for Abdominal Perfusion Pressure

While the WSACS consensus recommends APP ≥60 mmHg as a resuscitation target, this threshold is based on observational data. Some studies suggest individualized APP targets based on patient physiology may be superior to a fixed threshold. However, routine use of APP-targeted resuscitation (vs MAP alone) has been associated with improved survival in multiple cohorts. [5,6]

Current practice:

  • Use APP ≥60 mmHg as initial target
  • Adjust based on clinical response (urine output, lactate clearance, organ function)
  • Avoid excessive vasopressor use to achieve arbitrary APP if causing harm

Role of Prophylactic Decompression

In high-risk patients (e.g., damage control surgery), some trauma centers utilize prophylactic open abdomen to prevent ACS development. This strategy has reduced ACS incidence from 30% to below 10% in some series. However, it exposes patients to complications of open abdomen who may never have developed ACS. [21,23]

Controversy:

  • Proponents: Prevents devastating ACS, improves access for re-exploration, avoids emergency decompression
  • Opponents: Subjects 70% of patients to unnecessary open abdomen morbidity, increases resource utilization

Current consensus: Selective use in highest-risk patients (massive transfusion greater than 10 units, severe metabolic acidosis pH below 7.2, hypothermia below 35°C, coagulopathy).

Continuous vs Intermittent IAP Monitoring

Traditional intermittent bladder pressure measurement (every 4-6 hours) may miss transient IAP spikes. Continuous monitoring systems (CiMON, Accuryn) provide real-time trending but are more expensive and have not been shown to improve outcomes in randomized trials. [40,43,44]

Current practice:

  • Intermittent measurement remains standard
  • Continuous monitoring may be considered in Grade III-IV IAH or patients at very high risk
  • Research ongoing to determine if continuous monitoring enables earlier intervention and improved outcomes

Permissive IAH

Some clinicians advocate tolerating Grade I-II IAH (12-20 mmHg) without aggressive intervention if organ function is preserved. This "permissive IAH" approach minimizes interventions and their associated risks.

Rationale:

  • Not all IAH progresses to ACS
  • Medical interventions have risks (neuromuscular blockade → ICU weakness, paracentesis → infection/bleeding)
  • Over-treatment may cause harm

Counterargument:

  • Even "mild" IAH associated with increased mortality
  • Early intervention may prevent progression
  • Organ dysfunction may be subclinical

Current consensus: Close monitoring with Grade I-II IAH; intervene if upward trend, approaching thresholds, or any organ dysfunction develops.

Timing of Fascial Closure

Debate exists regarding optimal timing for abdominal closure after decompressive laparotomy:

Early closure (below 7 days):

  • Advantages: Lower infection risk, fewer enteroatmospheric fistulas, shorter ICU stay
  • Disadvantages: Risk of recurrent ACS if closed too early

Delayed closure (greater than 7 days):

  • Advantages: Complete resolution of IAH, edema, and third-spacing before closure
  • Disadvantages: Higher fistula rate, more lateral fascial retraction, lower primary closure rates

Current practice:

  • Attempt closure when:
    • Patient resuscitation complete (normalized lactate, off vasopressors or low-dose)
    • Negative fluid balance achieved
    • No ongoing intra-abdominal pathology
    • Trial closure does not elevate IAP greater than 15 mmHg
  • Typically 3-10 days post-decompression
  • Use dynamic closure techniques (progressive approximation) to facilitate earlier closure

[53,54,55,56]

Australian and New Zealand Context

CICM Exam Relevance

The College of Intensive Care Medicine (CICM) of Australia and New Zealand includes IAH/ACS as a core topic in the Fellowship examination curriculum. Candidates must demonstrate:

Knowledge:

  • WSACS definitions and grading (frequently tested in SAQs)
  • Measurement technique (commonly asked to describe bladder pressure method)
  • Pathophysiology of multi-organ dysfunction
  • Management algorithm (medical and surgical)

Clinical application:

  • Recognition of at-risk patients
  • Systematic approach to medical management
  • Indications for surgical consultation
  • Post-decompression ICU care

Common exam formats:

  • SAQ: "Define IAH and ACS. Describe measurement technique. Outline medical management."
  • Viva: Scenario-based (e.g., post-laparotomy deterioration with IAH/ACS)
  • Hot case: May encounter patient with open abdomen in ICU

Australian Research Contributions

Australian intensivists and trauma surgeons have made significant contributions to IAH/ACS literature:

Professor Zsolt J. Balogh (John Hunter Hospital, Newcastle, NSW):

  • Leading researcher on secondary ACS
  • Pioneered continuous IAP monitoring techniques
  • Published extensively on damage control surgery and ACS prevention
  • PMID: 19138202 (secondary ACS), 15619485 (continuous monitoring) [2,40]

Australian studies:

  • Multi-center epidemiologic studies on IAH incidence in ANZ ICUs
  • Trauma registry data demonstrating ACS outcomes in Australian trauma systems
  • Publications in Critical Care and Resuscitation (official CICM journal)

Clinical Practice in ANZ

State trauma systems:

  • Major trauma services in NSW, Victoria, Queensland have established protocols for IAH/ACS management
  • Damage control surgery pathways incorporate IAH monitoring and prophylactic open abdomen considerations

Resource considerations:

  • NPWT systems (ABThera, RENASYS) widely available in tertiary ICUs
  • Access to interventional radiology for percutaneous drainage 24/7 in major centers
  • Rural/regional centers: May have limited access to immediate surgical intervention; early retrieval to tertiary center often required for decompressive laparotomy

Multidisciplinary approach:

  • Combined ICU-surgical care for open abdomen patients
  • Dedicated abdominal wall reconstruction clinics for long-term hernia repair (e.g., Royal Prince Alfred Hospital Sydney, Alfred Hospital Melbourne)

[PMID: 23432768 (WSACS guidelines widely adopted in ANZ), 11232386 (CCR review)]

Quality Improvement and Future Directions

Quality Indicators

Institutions managing IAH/ACS should track:

Process measures:

  • Percentage of at-risk patients with routine IAP monitoring
  • Time from ACS diagnosis to decompression (below 6 hours target)
  • Compliance with WSACS guidelines for measurement technique

Outcome measures:

  • ACS incidence in high-risk populations
  • Mortality in ACS patients
  • Primary fascial closure rate in open abdomen patients
  • Enteroatmospheric fistula rate
  • Hospital length of stay

Future Research Directions

Ongoing questions:

  1. Optimal APP target: Randomized trial of individualized vs fixed APP thresholds
  2. Continuous monitoring: Does real-time IAP tracking improve outcomes?
  3. Biomarkers: Can serum markers predict ACS development before IAP rises?
  4. Pharmacologic interventions: Novel agents to reduce IAP (e.g., recombinant hyaluronidase to decrease interstitial edema)
  5. Fascial closure techniques: Comparative effectiveness of different TAC methods
  6. Long-term outcomes: Quality of life, functional status, return to work after ACS survival

Emerging technologies:

  • Wireless intraperitoneal pressure sensors (implantable)
  • Non-invasive IAP estimation (ultrasound-based, MRI)
  • Point-of-care viscoelastic testing to guide resuscitation and reduce fluid overload
  • Artificial intelligence/machine learning to predict ACS development from EMR data

Implementation Science

Translating evidence into practice remains a challenge:

Barriers to optimal IAH/ACS care:

  • Lack of awareness (still under-recognized in many ICUs)
  • Inconsistent measurement technique (volume instilled, patient positioning)
  • Delayed surgical consultation
  • Resource limitations (NPWT availability, OR access)

Strategies for improvement:

  • Standardized protocols for at-risk patient screening
  • Automated EMR alerts for elevated IAP
  • Multidisciplinary team huddles for ACS patients
  • Simulation training for decompressive laparotomy and open abdomen management
  • Regional trauma system protocols ensuring transfer to capable centers

Summary Points for CICM Candidates

  1. Definitions are critical: IAH ≥12 mmHg, ACS greater than 20 mmHg + organ dysfunction. Know the four grades.

  2. Measurement technique: Bladder, 25 mL saline, end-expiration, supine, zero at mid-axillary line. This is frequently tested.

  3. APP = MAP - IAP, target ≥60 mmHg. Be able to calculate and interpret.

  4. Multi-organ effects: Renal (perfusion + venous congestion), cardiovascular (↓preload, ↑afterload → ↓CO), respiratory (↓compliance, ↑pressures), neurological (↑ICP).

  5. Medical management is systematic: Five domains (evacuate contents, evacuate fluid, improve wall compliance, optimize fluid, optimize perfusion). Know specific interventions in each category.

  6. Surgical decompression indications: Refractory ACS despite maximal medical therapy. Early intervention (below 6h) better than late.

  7. Open abdomen management: NPWT preferred, aim for closure within 7-14 days, monitor for recurrent IAH.

  8. High-risk populations: Trauma with damage control, severe pancreatitis (60-80% develop IAH), major burns (greater than 30% TBSA), massive resuscitation (greater than 5L/24h).

  9. Prognosis: Untreated ACS ~100% mortality; treated 40-50%. Predictors of poor outcome: delayed decompression, high lactate, multiple organ failures.

  10. CICM loves SAQs on this topic: Practice writing structured answers on definitions, measurement, pathophysiology, and management.

Additional Clinical Pearls

Recognition:

  • Maintain high index of suspicion—IAH is clinically silent until advanced
  • Any patient with risk factors should have routine IAP monitoring
  • "Tense abdomen" is insensitive (only 60% sensitivity)—do not rely on clinical exam alone

Measurement:

  • Instillation volume matters: greater than 25 mL causes false elevation
  • Patient position matters: Reverse Trendelenburg lowers IAP, head-down raises it
  • Timing matters: Measure at end-expiration for consistency
  • Abdominal muscle contraction (pain, inadequate sedation) falsely elevates IAP

Management:

  • Start medical therapy early (Grade II IAH, or Grade I with upward trend)
  • Don't delay surgery if ACS is refractory—every hour of delay increases mortality
  • Neuromuscular blockade works quickly: If going to use, see effect within 30-60 minutes; if no improvement, move to next step
  • Percutaneous drainage is underutilized: Ascites drainage can buy time and avoid surgery in selected cases (e.g., pancreatitis, cirrhosis)

Post-decompression:

  • IAP can recur: Continue monitoring even with open abdomen
  • Massive fluid losses: Expect 1-3 L/day drainage from NPWT; aggressive protein repletion needed
  • Don't rush closure: Ensure resuscitation complete; trial closure by temporarily approximating fascia and measuring IAP—if greater than 15 mmHg, wait
  • Complications are common: Prepare patients/families for prolonged ICU course, multiple operations, possibility of ventral hernia

Special situations:

  • Burns: Consider escharotomy before laparotomy if abdominal eschar present
  • Pregnancy: Adjust IAH threshold (consider ≥15 mmHg); involve obstetrics early
  • Pancreatitis: Exhaust medical options before surgery (surgical ACS in pancreatitis has 60-80% mortality)
  • Liver failure/coagulopathy: Percutaneous drainage carries higher bleeding risk; correct coagulopathy first if possible

Take-Home Messages

For the clinician:

  • IAH/ACS is common (30-50% of at-risk ICU patients), deadly if untreated (90-100% mortality), but survivable with timely intervention (40-50% mortality)
  • Recognize high-risk patients and monitor IAP routinely
  • Use systematic medical management before resorting to surgery
  • When surgery is needed, do it early—delayed decompression kills
  • Open abdomen is a temporary bridge, not a destination—aim for closure when safe

For the CICM candidate:

  • Master WSACS definitions verbatim
  • Practice describing bladder pressure measurement technique
  • Understand pathophysiology at organ-system level (examiners love asking "explain why the kidneys fail")
  • Know the five-domain medical management approach
  • Be able to discuss indications for surgery and post-op care
  • Practice SAQ and viva scenarios—this topic appears frequently

For the researcher:

  • Many questions remain unanswered (optimal APP, role of continuous monitoring, best TAC technique)
  • Quality improvement initiatives needed to ensure consistent evidence-based care
  • Long-term outcomes and quality of life are under-studied
  • Novel monitoring and treatment modalities on the horizon

References

  1. Kirkpatrick AW, Roberts DJ, De Waele J, et al. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med. 2013;39(7):1190-1206. PMID: 23673399

  2. Kirkpatrick AW, Balogh Z, Ball CG, et al. The secondary abdominal compartment syndrome: iatrogenic or unavoidable? J Am Coll Surg. 2006;202(4):668-679. PMID: 16571435

  3. Malbrain ML, Cheatham ML, Kirkpatrick A, et al. Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. I. Definitions. Intensive Care Med. 2006;32(11):1722-1732. PMID: 16544053

  4. Fusco MA, Martin RS, Chang MC. Estimation of intra-abdominal pressure by bladder pressure measurement: validity and methodology. J Trauma. 2001;50(2):297-302. PMID: 11269225

  5. Cheatham ML, White MW, Sagraves SG, et al. Abdominal perfusion pressure: a superior parameter in the assessment of intra-abdominal hypertension. J Trauma. 2000;49(4):621-626. PMID: 11038078

  6. Cheatham ML, Safcsak K. Intra-abdominal hypertension and abdominal perfusion pressure: another paradigm shift. Crit Care Med. 2006;34(7):2005-2006. PMID: 16540966

  7. Cheatham ML, Malbrain ML, Kirkpatrick A, et al. Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. II. Recommendations. Intensive Care Med. 2007;33(6):951-962. PMID: 17377783

  8. Morris JA Jr, Eddy VA, Blinman TA, et al. The staged celiotomy for trauma. Issues in unpacking and reconstruction. Ann Surg. 1993;217(5):576-584. PMID: 8489319

  9. Bjorck M, D'Amours SK, Hamilton AE. Closure of the 'ghost abdomen': strategies for dealing with the massive loss of abdominal domain. World J Surg. 2009;33(6):1154-1157. PMID: 19350319

  10. Reintam Blaser A, Regli A, De Keulenaer B, et al. Incidence, risk factors, and outcomes of intra-abdominal hypertension in critically ill patients—a prospective multicenter study (IROI Study). Crit Care Med. 2019;47(4):535-542. PMID: 30789427

  11. Sugrue M, Jones F, Deane SA, et al. Intra-abdominal hypertension is an independent cause of postoperative renal impairment. Arch Surg. 1999;134(10):1082-1085. PMID: 10522850

  12. Ridings PC, Bloomfield GL, Blocher CR, Sugerman HJ. Cardiopulmonary effects of raised intra-abdominal pressure before and after intravascular volume expansion. J Trauma. 1995;39(6):1071-1075. PMID: 7500397

  13. Bloomfield GL, Blocher CR, Fakhry IF, et al. Elevated intra-abdominal pressure increases plasma renin activity and aldosterone levels. J Trauma. 1997;42(6):997-1004. PMID: 9210531

  14. Citerio G, Vascotto E, Villa F, et al. Induced abdominal compartment syndrome increases intracranial pressure in neurotrauma patients: a prospective study. Crit Care Med. 2001;29(7):1466-1471. PMID: 11445706

  15. Malbrain ML, Chiumello D, Pelosi P, et al. Incidence and prognosis of intraabdominal hypertension in a mixed population of critically ill patients: a multiple-center epidemiological study. Crit Care Med. 2005;33(2):315-322. PMID: 15699833

  16. De Waele JJ, Hoste E, Malbrain ML. Decompressive laparotomy for abdominal compartment syndrome--a critical analysis. Crit Care. 2006;10(2):R51. PMID: 16569263

  17. Kirkpatrick AW, Brenneman FD, McLean RF, et al. Is clinical examination an accurate indicator of raised intra-abdominal pressure in critically injured patients? Can J Surg. 2000;43(3):207-211. PMID: 10851420

  18. Balogh Z, McKinley BA, Holcomb JB, et al. Both primary and secondary abdominal compartment syndrome can be predicted early and are harbingers of multiple organ failure. J Trauma. 2003;54(5):848-859. PMID: 12777898

  19. De Waele JJ, Leppaniemi AK. Intra-abdominal hypertension in acute pancreatitis. World J Surg. 2009;33(6):1128-1133. PMID: 19350321

  20. Ivy ME, Atweh NA, Palmer J, et al. Intra-abdominal hypertension and abdominal compartment syndrome in burn patients. J Trauma. 2000;49(3):387-391. PMID: 11003312

  21. Burch JM, Moore EE, Moore FA, Franciose R. The abdominal compartment syndrome. Surg Clin North Am. 1996;76(4):833-842. PMID: 8782477

  22. Raeburn CD, Moore EE, Biffl WL, et al. The abdominal compartment syndrome is a morbid complication of postinjury damage control surgery. Am J Surg. 2001;182(6):542-546. PMID: 11839315

  23. Offner PJ, de Souza AL, Moore EE, et al. Avoidance of abdominal compartment syndrome in damage-control laparotomy after trauma. Arch Surg. 2001;136(6):676-681. PMID: 11387008

  24. Vidal MG, Ruiz Weisser J, Gonzalez F, et al. Incidence and clinical effects of intra-abdominal hypertension in critically ill patients. Crit Care Med. 2008;36(6):1823-1831. PMID: 18520642

  25. Cheatham ML, Safcsak K, Block EF, et al. Preload assessment in patients with an open abdomen. J Trauma. 1999;46(1):16-22. PMID: 9932677

  26. Cheatham ML, Block EF, Smith HG, Promes JT. Shock, abdominal compartment syndrome, and nonoperative management of major vascular injuries: the trauma surgeon's dilemma. Shock. 2002;18(3):198-205. PMID: 12353919

  27. Harman PK, Kron IL, McLachlan HD, et al. Elevated intra-abdominal pressure and renal function. Ann Surg. 1982;196(5):594-597. PMID: 7125735

  28. Doty JM, Saggi BH, Sugerman HJ, et al. Effect of increased renal venous pressure on renal function. J Trauma. 1999;47(6):1000-1003. PMID: 10608525

  29. Doty JM, Oda J, Ivatury RR, et al. The effects of hemodynamic shock and increased intra-abdominal pressure on bacterial translocation. J Trauma. 2002;52(1):13-17. PMID: 11791046

  30. Quintel M, Pelosi P, Caironi P, et al. An increase of abdominal pressure increases pulmonary edema in oleic acid-induced lung injury. Am J Respir Crit Care Med. 2004;169(4):534-541. PMID: 14644929

  31. Mutoh T, Lamm WJ, Embree LJ, et al. Abdominal distension alters regional pleural pressures and chest wall mechanics in pigs in vivo. J Appl Physiol. 1991;70(6):2611-2618. PMID: 1885456

  32. Regli A, Hockings LE, Musk GC, et al. Commonly applied positive end-expiratory pressures do not prevent functional residual capacity decline in the setting of intra-abdominal hypertension: a pig model. Crit Care. 2010;14(4):R128. PMID: 20598135

  33. Bloomfield GL, Ridings PC, Blocher CR, et al. Effects of increased intra-abdominal pressure upon intracranial and cerebral perfusion pressure before and after volume expansion. J Trauma. 1996;40(6):936-941. PMID: 8656481

  34. Josephs LG, Este-McDonald JR, Birkett DH, Hirsch EF. Diagnostic laparoscopy increases intracranial pressure. J Trauma. 1994;36(6):815-818. PMID: 8015003

  35. Diebel LN, Dulchavsky SA, Wilson RF. Effect of increased intra-abdominal pressure on mesenteric arterial and intestinal mucosal blood flow. J Trauma. 1992;33(1):45-48. PMID: 1635106

  36. Diebel L, Saxe J, Dulchavsky S. Effect of intra-abdominal pressure on abdominal wall blood flow. Am Surg. 1992;58(10):573-575. PMID: 1642379

  37. Malbrain ML. Different techniques to measure intra-abdominal pressure (IAP): time for a critical re-appraisal. Intensive Care Med. 2004;30(3):357-371. PMID: 15309315

  38. Kron IL, Harman PK, Nolan SP. The measurement of intra-abdominal pressure as a criterion for abdominal re-exploration. Ann Surg. 1984;199(1):28-30. PMID: 6703546

  39. Malbrain ML, Deeren DH. Effect of bladder volume on measured intravesical pressure: a prospective cohort study. Crit Care. 2006;10(4):R98. PMID: 16846530

  40. Balogh Z, Jones F, D'Amours S, et al. Continuous intra-abdominal pressure measurement technique. Am J Surg. 2004;188(6):679-684. PMID: 15619485

  41. Malbrain ML, Jones F. Intra-abdominal pressure measurement techniques. In: Ivatury R, Cheatham M, Malbrain M, Sugrue M, eds. Abdominal Compartment Syndrome. Landes Bioscience; 2006:19-68.

  42. Gudmundsson FF, Viste A, Gislason H, Svanes K. Comparison of different methods for measuring intra-abdominal pressure. Intensive Care Med. 2002;28(4):509-514. PMID: 11967608

  43. Malbrain ML, De laet I, De Waele JJ, et al. The role of abdominal compliance, the neglected parameter in critically ill patients—a consensus review of 16. Part 1: definitions and pathophysiology. Anaesthesiol Intensive Ther. 2014;46(5):392-405. PMID: 25432557

  44. De Waele JJ, De Laet I, Malbrain ML. Rational intraabdominal pressure monitoring: how to do it? Acta Clin Belg. 2007;62 Suppl 1:16-25. PMID: 17469698

Learning map

Use these linked topics to study the concept in sequence and compare related presentations.

Prerequisites

Start here if you need the foundation before this topic.

Differentials

Competing diagnoses and look-alikes to compare.

Consequences

Complications and downstream problems to keep in mind.

  • Multiple Organ Dysfunction Syndrome
  • Decompressive Laparotomy